Percutaneous cool-tip radiofrequency ablation for T_(1a) renal cell carcinoma
WANG Guangchun,ZHU Wei,WANG Bo,GENG Jiang,HUANG Jianhua,XIA Shengqiang,LUO Ming,CHE Jianping,YAN Yang,KANG Li,PENG Bo,XU Yunfei,ZHENG Junhua
2013-01-01
Abstract:Objective To investigate the safety and therapeutic effects of percutaneous cool-tip radiofrequency ablation for T1arenal cell carcinoma.Methods Fifteen patients was diagnosed as T1asingle renal cell carcinoma and received percutaneous cool-tip radiofrequency ablation.Six tumors were located in the left kidney and nine in the right side.Enhanced CT scanning was performed before surgery to identify tumor size and location.The average tumor diameter was(2.7±1.1)cm(range,1.1-3.9cm).During postoperative follow-up period,all patients received enhanced CT scanning.Hemoglobin(Hb),serum creatinine(sCr),erythrocyte sedimentation rate(ESR)and glomerular filtration rate(GFR)were detected before surgery,on one day,one week,one month and three months after surgery.Results Percutaneous cool-tip radiofrequency ablation was successfully performed in the 15cases.There were no severe complications.All the patients were discharged on day 2postoperatively.Compared with preoperative values,there were no significant differences in Hb,sCr,ESR and GFR on one day,one week,one month and three months after surgery(all P>0.05).One week after operation,low density shadow was found in the tumor region.One month after operation,complete ablation was achieved in 13cases and partial ablation in 2cases,with an ablation rate of 13/15.Three months after operation,14lesions were completely necrotic and only one lesion was partially necrotic,with an ablation rate of 13/15.During the follow-up period of 2—22months(mean,9.3months),all the 15patients survived and no recurrence or metastasis was found.Conclusion Percutaneous cool-tip radiofrequency ablation is a safe,effective and minimally invasive treatment for T1arenal cell carcinoma.